Study: DTC ads for breast cancer drugs hit target

11/26/2012 | Medical Marketing & Media

Direct-to-consumer campaigns for three aromatase inhibitors did not spur more prescriptions for premenopausal breast cancer patients but may have increased prescriptions for postmenopausal patients, for whom the drugs are indicated, a study published in the journal Cancer found.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA